Updated Controlled Drugs Regulations from 1st April 2013
28th February 2013
Controlled Drugs (Supervision of Management and Use) Regulations 2013 (SI2103/373) for England and Scotland will come into force on 1st April 2013. These deal with governance arrangements, in particular the role and functions of Controlled Drugs Accountable Officers (CDAO), and also reflect the new architecture for the NHS in England from April 2013.
These regulations supersede the Controlled Drugs (Supervision of Management and Use) Regulations 2006 (“the 2006 Regulations”) which came into force in 2007, and follow a consultation process by the Department of Health (DH) in September 2012 (see our article 28-09-2012).
The DH has published information about the 2013 Regulations which can be downloaded below, along with the official Regulations and the summary of responses to the consultation.
- NICE: Care of dying adults in the last days of life quality standard
- Cochrane review: topical capsaicin (high concentration) for chronic neuropathic pain in adults
- Thalidomide updated SPC
- Scottish Medicines Consortium: Noqdirna
- NICE evidence summary: oral glycopyrronium bromide for severe sialorrhoea
- Cochrane review: pharmacological interventions for pruritus in adult palliative care patients
- Cochrane review: paracetamol with or without codeine or dihydrocodeine for neuropathic pain in adults
- Scottish Medicines Consortium: Butec patches for chronic non-malignant pain
- Glycopyrronium oral solution authorized for drooling now available in UK
- FDA approves 2mg naloxone nasal spray